• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



PAA PharmAust enters option to license agreement with ElancoPRICE SENSITIVE18/04/18
PAA Trading HaltPRICE SENSITIVE16/04/18
PAA Wayne Best appointed Epichem Chairman and Dr Keenan as CEO10/04/18
PAA Cleansing Notice20/03/18
PAA Change of Director's Interest Notice x 316/03/18
PAA Appendix 3B & s708 notice16/03/18
PAA Collaboration with Olivia Newton-John Cancer Research Inst14/03/18
PAA Appendix 4D and Half Yearly Report & AccountsPRICE SENSITIVE28/02/18
PAA PharmAust receives $354k R&D Tax Incentive RefundPRICE SENSITIVE28/02/18
PAA Results of General Meeting26/02/18
PAA Monepantel reformulation successfully improves dose & tastePRICE SENSITIVE30/01/18
PAA PharmAust enters option to license agreement with Elanco
18/04/18PRICE SENSITIVE
PAA Trading Halt
16/04/18PRICE SENSITIVE
PAA Wayne Best appointed Epichem Chairman and Dr Keenan as CEO
10/04/18
PAA Cleansing Notice
20/03/18
PAA Change of Director's Interest Notice x 3
16/03/18
PAA Appendix 3B & s708 notice
16/03/18
PAA Collaboration with Olivia Newton-John Cancer Research Inst
14/03/18
PAA Appendix 4D and Half Yearly Report & Accounts
28/02/18PRICE SENSITIVE
PAA PharmAust receives $354k R&D Tax Incentive Refund
28/02/18PRICE SENSITIVE
PAA Results of General Meeting
26/02/18
PAA Monepantel reformulation successfully improves dose & taste
30/01/18PRICE SENSITIVE
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.